FEED the BULL

Welcome to Feed the Bull - A home for investment information and interaction.

Tag: ovarian cancer

Sort
E.g., 2013-05-20
E.g., 2013-05-20
Enter a comma separated list of user names.

** Barnes & Noble (BKS) posted $1.4 billion in total sales for the first quarter 2012, a 2% increase compared to the prior year.

*********************

** Limelight Networks (LLNW) reported the sale of its EyeWonder rich media advertising unit to DG FastChannel for approximately $66 million.

*********************

EntreMed (ENMD) reported clinical data for its Phase 2 study with ENMD-2076 in platinum-resistant ovarian cancer patients.

The trial was an open-label, single-arm, multi-center-study of ENMD-2076 dosed orally as a single agent in patients with platinum-resistant recurrent ovarian, peritoneal or tubal cancer.

There has been new research announced in an article on Bloomberg's Business Week that discusses mutated genes and the impact on the likelihood of getting ovarian cancer. In this arena, neurotoxicity in therapies has also been a constant bane in the side of researchers, drug manufacturers (and, subsequently, patients).

ADVERTISE WITH US